174 related articles for article (PubMed ID: 33679129)
1. Low Frequency of Integrase Inhibitor Resistance Mutations Among Therapy-Naïve HIV Patients in Southeast China.
Lai J; Liu Y; Han X; Huang A; Lin J; Ao W; Ye H; Chen Y
Drug Des Devel Ther; 2021; 15():889-894. PubMed ID: 33679129
[TBL] [Abstract][Full Text] [Related]
2. Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.
Chen GJ; Cheng CY; Yang CJ; Lee NY; Tang HJ; Huang SH; Huang MH; Liou BH; Lee YC; Lin CY; Hung TC; Lin SP; Sun HY; Chang SY; Hung CC;
J Antimicrob Chemother; 2024 May; 79(5):1157-1163. PubMed ID: 38546761
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020).
Yang Z; Yang X; Deng X; Wei S; Liu J; Ma J; Zhao Q; Huo Y
Infection; 2021 Dec; 49(6):1195-1202. PubMed ID: 34279816
[TBL] [Abstract][Full Text] [Related]
4. Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe.
de Salazar A; Viñuela L; Fuentes A; Teyssou E; Charpentier C; Lambert-Niclot S; Serrano-Conde E; Pingarilho M; Fabeni L; De Monte A; Stefic K; Perno CF; Aguilera A; Falces I; Delgado R; Fernandes S; Diogo I; Gomes P; Paraskevis D; Santoro MM; Ceccherini-Silberstein F; Marcelin AG; Garcia F
Clin Infect Dis; 2023 May; 76(9):1628-1635. PubMed ID: 36571282
[TBL] [Abstract][Full Text] [Related]
5. Variability in HIV-1 Integrase Gene and 3'-Polypurine Tract Sequences in Cameroon Clinical Isolates, and Implications for Integrase Inhibitors Efficacy.
Acharya A; Tagny CT; Mbanya D; Fonsah JY; Nchindap E; Kenmogne L; Jihyun M; Njamnshi AK; Kanmogne GD
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106437
[No Abstract] [Full Text] [Related]
6. Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors.
Hu Z; Kuritzkes DR
J Virol; 2014 Aug; 88(16):9268-76. PubMed ID: 24899199
[TBL] [Abstract][Full Text] [Related]
7. Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir.
Oliveira M; Ibanescu RI; Anstett K; Mésplède T; Routy JP; Robbins MA; Brenner BG;
Retrovirology; 2018 Aug; 15(1):56. PubMed ID: 30119633
[TBL] [Abstract][Full Text] [Related]
8. A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection.
Zhao AV; Crutchley RD; Guduru RC; Ton K; Lam T; Min AC
Retrovirology; 2022 Oct; 19(1):22. PubMed ID: 36273165
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and analysis of acquired and transmitted integrase strand transfer inhibitor-associated HIV-1 drug resistance in Chongqing, China.
Zhang H; Wu P; Li J; Li M
Virulence; 2023 Dec; 14(1):2278254. PubMed ID: 37941373
[TBL] [Abstract][Full Text] [Related]
10. Identification of integrase inhibitor-related drug resistance mutations in newly diagnosed ART-naïve HIV patients.
Wang N; Xiong X; Liu Z; Zhang R; Luo S; Zhang H; Wu X
Microb Pathog; 2023 Aug; 181():106217. PubMed ID: 37385569
[TBL] [Abstract][Full Text] [Related]
11. Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-2018.
McClung RP; Oster AM; Ocfemia MCB; Saduvala N; Heneine W; Johnson JA; Hernandez AL
Clin Infect Dis; 2022 Mar; 74(6):1055-1062. PubMed ID: 34175948
[TBL] [Abstract][Full Text] [Related]
12. Integrase Strand Transfer Inhibitor (INSTI) Genotypic Resistance Analysis in Treatment-Naive, INSTI Free Antiretroviral-Experienced and INSTI-Experienced Turkish Patients Infected with HIV-1.
Sayan M; Yildirim FS; Akhan S; Karaoglan I; Akalin H
Curr HIV Res; 2022 Aug; 20(2):184-192. PubMed ID: 35240975
[TBL] [Abstract][Full Text] [Related]
13. Integrase Strand Transfer Inhibitors (INSTIs) Resistance Mutations in HIV-1 Infected Turkish Patients.
Sayan M; Gündüz A; Ersöz G; İnan A; Deveci A; Özgür G; Sargın F; Karagöz G; İnci A; İnan D; Ülçay A; Karaoğlan I; Kaya S; Kutlu SS; Süer K; Çağatay A; Akalın H
HIV Clin Trials; 2016 May; 17(3):109-13. PubMed ID: 27125365
[TBL] [Abstract][Full Text] [Related]
14. Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa.
Obasa AE; Mikasi SG; Brado D; Cloete R; Singh K; Neogi U; Jacobs GB
Front Microbiol; 2020; 11():438. PubMed ID: 32265875
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of resistance to integrase strand-transfer inhibitors (INSTIs) among untreated HIV-1 infected patients in Morocco.
Alaoui N; El Alaoui MA; Touil N; El Annaz H; Melloul M; Tagajdid R; Hjira N; Boui M; El Fahime EM; Mrani S
BMC Res Notes; 2018 Jun; 11(1):369. PubMed ID: 29884219
[TBL] [Abstract][Full Text] [Related]
16. Integrase Strand Transfer Inhibitor Resistance in Integrase Strand Transfer Inhibitor-Naive Persons.
Bailey AJ; Rhee SY; Shafer RW
AIDS Res Hum Retroviruses; 2021 Oct; 37(10):736-743. PubMed ID: 33683148
[TBL] [Abstract][Full Text] [Related]
17. Differences in the integrase and reverse transcriptase transmitted resistance patterns in Northern Poland.
Parczewski M; Leszczyszyn-Pynka M; Urbańska A
Infect Genet Evol; 2017 Apr; 49():122-129. PubMed ID: 28017912
[TBL] [Abstract][Full Text] [Related]
18. Low level of HIV-1C integrase strand transfer inhibitor resistance mutations among recently diagnosed ART-naive Ethiopians.
Kiros M; Tefera DA; Andualem H; Geteneh A; Tesfaye A; Woldemichael TS; Kidane E; Alemayehu DH; Maier M; Mihret A; Abegaz WE; Mulu A
Sci Rep; 2023 Apr; 13(1):6546. PubMed ID: 37085698
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of primary resistance mutations to integrase inhibitors in treatment-naïve and -experienced patients infected with B and non-B HIV-1 variants.
Gutiérrez C; Hernández-Novoa B; Pérez-Elías MJ; Moreno AM; Holguín A; Dronda F; Casado JL; Moreno S
HIV Clin Trials; 2013; 14(1):10-6. PubMed ID: 23372110
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of antiretrovirals in HIV-infected patients with cancer.
Torres HA; Rallapalli V; Saxena A; Granwehr BP; Viola GM; Ariza-Heredia E; Adachi JA; Chemaly RF; Marfatia R; Jiang Y; Mahale P; Kyvernitakis A; Fanale MA; Mulanovich V
Clin Microbiol Infect; 2014 Oct; 20(10):O672-9. PubMed ID: 24529214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
